Cargando…
Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy
Globoid-cell Leukodystrophy (GLD; Krabbe’s disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphingosine...
Autores principales: | Reddy, Adarsh S., Patel, Jigisha R., Vogler, Carole, Klein, Robyn S., Sands, Mark S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670857/ https://www.ncbi.nlm.nih.gov/pubmed/23755134 http://dx.doi.org/10.1371/journal.pone.0064647 |
Ejemplares similares
-
Bone Marrow Transplantation Alters the Tremor Phenotype in the Murine Model of Globoid-Cell Leukodystrophy
por: Reddy, Adarsh S., et al.
Publicado: (2012) -
Globoid Cell Leukodystrophy (Krabbe Disease): An Update
por: Maghazachi, Azzam A
Publicado: (2023) -
Exonic deletions in GALC are frequent in Japanese globoid-cell leukodystrophy patients
por: Irahara-Miyana, Kaori, et al.
Publicado: (2018) -
A neglected neurodegenerative disease: Adult-onset globoid cell leukodystrophy
por: Wu, Guode, et al.
Publicado: (2022) -
Neural Stem Cell Gene Therapy Ameliorates Pathology and Function in a Mouse Model of Globoid Cell Leukodystrophy
por: Neri, Margherita, et al.
Publicado: (2011)